Hassan Sibai

941 total citations
69 papers, 369 citations indexed

About

Hassan Sibai is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hassan Sibai has authored 69 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 31 papers in Genetics and 23 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hassan Sibai's work include Acute Myeloid Leukemia Research (36 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers) and Acute Lymphoblastic Leukemia research (23 papers). Hassan Sibai is often cited by papers focused on Acute Myeloid Leukemia Research (36 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (24 papers) and Acute Lymphoblastic Leukemia research (23 papers). Hassan Sibai collaborates with scholars based in Canada, United States and Australia. Hassan Sibai's co-authors include Vikas Gupta, Karen Yee, Aaron D. Schimmer, Mark D. Minden, Dawn Maze, Andre C. Schuh, Steven M. Chan, Caroline McNamara, Jeffrey H. Lipton and Tracy Murphy and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Hassan Sibai

61 papers receiving 365 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hassan Sibai Canada 11 226 118 87 72 59 69 369
Aline Schmidt France 11 320 1.4× 153 1.3× 62 0.7× 130 1.8× 139 2.4× 44 526
Gianna Maria D’Elia Italy 13 159 0.7× 116 1.0× 42 0.5× 57 0.8× 128 2.2× 33 357
P G Cachia United Kingdom 10 212 0.9× 82 0.7× 52 0.6× 26 0.4× 33 0.6× 21 363
Ilaria Nichele Italy 11 142 0.6× 209 1.8× 82 0.9× 27 0.4× 64 1.1× 23 413
Chiara Sarlo Italy 10 302 1.3× 90 0.8× 88 1.0× 148 2.1× 42 0.7× 25 402
Yeu‐Chin Chen Taiwan 11 136 0.6× 46 0.4× 54 0.6× 17 0.2× 51 0.9× 55 313
Tzung‐Chih Tang Taiwan 14 216 1.0× 111 0.9× 147 1.7× 34 0.5× 146 2.5× 33 507
Angela Rago Italy 10 179 0.8× 136 1.2× 72 0.8× 31 0.4× 67 1.1× 29 334
M. Bhavnani United Kingdom 13 335 1.5× 178 1.5× 50 0.6× 25 0.3× 45 0.8× 23 514
R. Grace United Kingdom 8 147 0.7× 52 0.4× 34 0.4× 54 0.8× 68 1.2× 17 352

Countries citing papers authored by Hassan Sibai

Since Specialization
Citations

This map shows the geographic impact of Hassan Sibai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hassan Sibai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hassan Sibai more than expected).

Fields of papers citing papers by Hassan Sibai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hassan Sibai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hassan Sibai. The network helps show where Hassan Sibai may publish in the future.

Co-authorship network of co-authors of Hassan Sibai

This figure shows the co-authorship network connecting the top 25 collaborators of Hassan Sibai. A scholar is included among the top collaborators of Hassan Sibai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hassan Sibai. Hassan Sibai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Qianghua, et al.. (2025). Molecular genetic characterization of mixed-phenotype acute leukemia (MPAL) with BCR::ABL1 fusion. Leukemia Research. 151. 107665–107665. 1 indexed citations
2.
Richard‐Carpentier, Guillaume, Séverine Cathelin, Lisa Wang, et al.. (2025). Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial. The Lancet Haematology. 12(11). e887–e897.
3.
Zhou, Qianghua, et al.. (2025). Genomic Profile and Clinical Outcomes in Acute Myeloid Leukemia with Monosomal Karyotype. International Journal of Molecular Sciences. 26(12). 5845–5845.
4.
Lucero, Josephine Anne, Igor Novitzky‐Basso, José‐Mario Capo‐Chichi, et al.. (2024). Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation. Annals of Hematology. 103(4). 1187–1196. 3 indexed citations
5.
Davidson, Marta, James A. Kennedy, José‐Mario Capo‐Chichi, et al.. (2024). Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN. Blood Advances. 8(5). 1281–1294. 5 indexed citations
6.
7.
Atenafu, Eshetu G., Taylor Young, Steven M. Chan, et al.. (2022). Safety of re‐challenging adults with acute lymphoblastic leukemia with PEG‐asparaginase‐induced severe hypertriglyceridemia when treated with a pediatric‐inspired regimen. SHILAP Revista de lepidopterología. 4(1). 232–235. 2 indexed citations
8.
Sibai, Hassan, et al.. (2022). Foot gangrene following Tagraxofusp treatment for blastic plasmacytoid dendritic cell neoplasm: Case report. SHILAP Revista de lepidopterología. 3(4). 1374–1376. 3 indexed citations
9.
Passamonti, Francesco, James M. Foran, Valerio De Stefano, et al.. (2022). The Combination of Navitoclax and Ruxolitinib in JAK Inhibitor-Naïve Patients with Myelofibrosis Mediates Responses Suggestive of Disease Modification. Blood. 140(Supplement 1). 583–585. 10 indexed citations
10.
Yee, Karen, et al.. (2022). Clinical implementation of genetic testing in adults for hereditary hematologic malignancy syndromes. Genetics in Medicine. 24(11). 2367–2379. 2 indexed citations
11.
Sibai, Hassan, et al.. (2021). Hemophagocytosis arising during disease progression of chronic myelomonocytic leukemia. International Journal of Laboratory Hematology. 44(1). 25–26.
12.
13.
Chen, Ruiqi, Arjun Law, Dawn Maze, et al.. (2020). Risk of Thrombosis in Adult Philadelphia-Positive ALL Treated with an Asparaginase-Free ALL Regimen. Current Oncology. 28(1). 128–137.
14.
Lam, Wilson, Arjun Law, Tracy Murphy, et al.. (2019). Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML): Princess Margaret Cancer Centre Experience. Blood. 134(Supplement_1). 2609–2609. 1 indexed citations
15.
16.
Sibai, Hassan, et al.. (2016). A critical review of treatment modalities for blastic plasmacytoid dendritic cell neoplasm. Critical Reviews in Oncology/Hematology. 107. 156–162. 14 indexed citations
17.
Sibai, Hassan, et al.. (2016). Ponatinib in the therapy of chronic myeloid leukemia. Expert Review of Hematology. 9(10). 923–932. 25 indexed citations
18.
Sibai, Hassan, Arjun Law, Eshetu G. Atenafu, et al.. (2016). Anticoagulation Prophylaxis in Asparaginase-Based Therapy in Adults with Acute Lymphoblastic Leukemia. Blood. 128(22). 1453–1453. 2 indexed citations
19.
Shamseddine, Ali, Eileen M. O’Reilly, Ali Haydar, et al.. (2013). A young woman with liver cancer. Scopus. 1 indexed citations
20.
Ang, Celina, Richard Kinh Gian, Ali Shamseddine, et al.. (2013). A young woman with liver cancer.. PubMed. 6(1). 17–21. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aline Schmidt Breakdown of academic impact, for papers by Gianna Maria D’Elia Breakdown of academic impact, for papers by P G Cachia Breakdown of academic impact, for papers by Ilaria Nichele Breakdown of academic impact, for papers by Chiara Sarlo Breakdown of academic impact, for papers by Yeu‐Chin Chen Breakdown of academic impact, for papers by Tzung‐Chih Tang Breakdown of academic impact, for papers by Angela Rago Breakdown of academic impact, for papers by M. Bhavnani Breakdown of academic impact, for papers by R. Grace
Rankless by CCL
2026